H Schulze-Koops
[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]
Fiehn C, Kuipers J, Lorenz H, Müller-Ladner U, Nothacker M, Nüsslein H, Rubbert-Roth A, Schneider M, Schulze-Koops H, Seitz S, Sitter H, Specker C, Tony H, Wassenberg S, Wollenhaupt J, Krause A, Kellner H, Gromnica-Ihle E, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Krüger K. [S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]. Z Rheumatol 2018; 77:35-53.
01.08.2018[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]
01.08.2018Z Rheumatol 2018; 77:35-53
Fiehn C, Kuipers J, Lorenz H-M, Müller-Ladner U, Nothacker M, Nüsslein H, Rubbert-Roth Andrea, Schneider M, Schulze-Koops H, Seitz S, Sitter H, Specker C, Tony H-P, Wassenberg S, Wollenhaupt J, Krause A, Kellner H, Gromnica-Ihle E, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Krüger K
The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis
Müller R, Schiff M, Kaegi T, Finckh A, Haile S, Schulze-Koops H, von Kempis J, Swiss Clinical Quality Management (SCQM) physicians. The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis. Clin Rheumatol 2014; 34:51-9.
15.07.2014The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis
15.07.2014Clin Rheumatol 2014; 34:51-9
Müller Rüdiger, Schiff M, Kaegi T, Finckh A, Haile Sarah, Schulze-Koops H, von Kempis Johannes, Swiss Clinical Quality Management (SCQM) physicians
MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritis
Müller R, Skapenko A, Wendler J, Schuch F, Kalden J, Schulze-Koops H. MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritis. Rheumatology (Oxford, England) 2007; 46:931-3.
01.06.2007MHC class II expression on myeloid cells inversely correlates with disease progression in early rheumatoid arthritis
01.06.2007Rheumatology (Oxford, England) 2007; 46:931-3
Müller Rüdiger, Skapenko A, Wendler J, Schuch F, Kalden J R, Schulze-Koops H